Table 1. Cancer therapeutics targeting highly conserved unicellular processes.
Drug | Mechanism of action | Targeted cancer type | Reference/reviewed in |
---|---|---|---|
Pemetrexed | Purine and pyrimidine synthesis | Lung cancer | Hanna et al (2004) |
Bortezomib | Proteasome | Myeloma and lymphoma | Piperdi et al (2011), Richardson et al (2003) |
Vincristine, vinblastine, vinorelbine | Suppression or depolymerisation of microtubules, destruction of mitotic spindles | Broad spectrum | Jordan and Wilson (2004) |
Paclitaxel | Microtubule-stabilisation, inducing mitotic arrest | Ovarian, breast, lung, gastroesophageal, endometrial, cervical, prostate, and head and neck cancers, sarcoma, lymphoma, and leukaemia | Weaver (2014) |
Camptothecin | Targets DNA topoisomerase I | Broad spectrum | Liu et al (2000) |